Lv3
300 积分 2025-12-01 加入
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
9天前
已完结
Incretin-based therapies for liver disease
18天前
已完结
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
18天前
已完结
Hepatic danger signaling triggers TREM2+ macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
18天前
已完结
The NLRP3 inflammasome: activation and regulation
19天前
已完结
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
19天前
已完结
Next-generation therapeutics for diabetic kidney disease
19天前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
20天前
已完结
Mechanism of NLRP3 inflammasome promoting hepatic stellate cell activation
27天前
已完结
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease
1个月前
已完结
皖公网安备34019202002308
